Amrutanjan Health Care
Amrutanjan Health Care Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
12.37 PM Jan 13th
Amrutanjan Health Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 10, 2016, inter alia, has declared 1st Interim Dividend of Rs. 1.10/- per share for the year 2016-2017 on the Equity Shares of the Company.The Board Meeting commenced at 11
5.26 PM Nov 10th 2016
*Amrutanjan Health Care Ltd.* *Result improved* Net Sales came at Rs. 54.8 Cr vs QoQ Rs. 34.4 Cr, YoY Rs. 44.7 Cr EBIDTA came at Rs. 11.4 Cr vs QoQ Rs. 2.6 Cr, YoY Rs. 9.4 Cr EBITDA Margin came at 20.8%, QoQ 7.5%, YoY 21% Adj. PAT came at Rs. 7.9 Cr vs QoQ Rs. 2.1 Cr, YoY Rs. 7.3 Cr Quarter EPS
4.59 PM Nov 10th 2016
Amrutanjan Health Care Ltd has informed BSE that a meeting of the Board of Directors is scheduled to be held on November 10, 2016, inter alia, to consider and approve the following:1. Unaudited Standalone Financial Results together with Limited Review Report of the Auditors for the quarter
6.16 PM Nov 7th 2016
Amrutanjan Health Care Ltd has informed BSE regarding the details of Voting results at the 79th Annual General Meeting (AGM) of the Company held on September 22, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizers Report.
6.00 PM Sep 23rd 2016
Amrutanjan Health Care Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 11, 2013, inter alia, to consider the following :1. Un-audited Financial Results for the quarter / nine months ended December 31, 2012.2. Interim Dividend.
4.57 PM Feb 5th 2013
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.